A 30-page procurement reference for the four segments of US clinical decision-makers buying or recommending peptides. Free quarterly edition. No affiliate links. No supplier endorsements. Editorial independence is the entire point.
Subscribers receive future quarterly editions automatically. No spam.
Three regulatory currents, four segments, where you sit in the supply chain.
12-point diligence framework for telehealth, peptide therapy, med spas.
What’s on a real COA, four red flags suggesting fabrication, retesting protocol.
FDA Cat 1/2 status, Import Alerts, 503A vs 503B, MoCRA implications.
Pharmacy partner red flags, API supplier red flags, telehealth-specific.
Advanced direct API import path. 21-day workflow, when not to use it.
Retail, wholesale, direct API. Lead times. Total landed cost.
Quarterly diligence cycle, semi-annual reviews, annual re-qualification.
Each chapter opens with a “Relevant to” tag identifying which segments will get the most value. Read what applies to your operation. Skip what doesn’t.
No affiliate links. No supplier endorsements. No marketplace listings. Best Peptide Source is editorial. Revenue model: paid subscriber editions, pharmacy directory listings (different from supplier listings — pharmacies are buyers, not suppliers), and sponsored content from regulatory consultants and equipment vendors with full disclosure.
30 pages. Free. Subscribers automatically receive future quarterly editions.